CompletedPhase 2NCT00263887

Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients (EXACTLE)

Studying Alpha-1-antitrypsin deficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Grifols Therapeutics LLC
Principal Investigator
Asger Dirksen, MD PHD
University of Copenhagen
Intervention
Alpha1-Proteinase Inhibitor (Human)(drug)
Enrollment
77 enrolled
Eligibility
18 years · All sexes
Timeline
20032007

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00263887 on ClinicalTrials.gov

Other trials for Alpha-1-antitrypsin deficiency

Additional recruiting or active studies for the same condition.

See all trials for Alpha-1-antitrypsin deficiency

← Back to all trials